Granted Patent B2

US 7,214,546 · App. 10/038,626 · Granted May 8, 2007

Assignee: Applera Corporation

Abstract

Claims (60)

1. A chemiluminescent substrate delivery system represented by a formula selected from the group consisting of:

wherein:

“Linker” represents a linker moiety;

“Dendrimer” represents a dendrimer moiety resulting from the reaction of a surface functional group on the dendrimer with a functional group on the linker moiety wherein said dendrimer moiety comprises chemiluminescent enhancing moieties selected from the group consisting of albumins, water soluble polymeric quaternary ammonium salts, water soluble polymeric quaternary sulfonium salts, water soluble polymeric quaternary phosphonium salts and mixtures thereof;

N is a positive integer representing the number of chemiluminescent substrates conjugated to the dendrimer moiety;

Y is H, a hydroxyl group, a halogen, an unsubstituted alkyl group, a hydroxy substituted alkyl group, a halogen substituted alkyl group, a phenyl group, a halogenated phenyl group, an alkoxy substituted phenyl group, an alkoxy phenoxy group, a hydroxy alkoxy group, a cyano group, an amide group, an alkoxy group or a carboxyl group;

R is a C 1 –C 12 alkyl, mono-, di-, or trihaloalkyl, an aryl or an aralkyl;

X is an enzyme-labile group selected from the group consisting of a phosphate, galactoside, acetate, 1-phospho-2,3-diacylglyceride, 1-thio-D-glucoside, adenosine triphosphate, adenosine diphosphate, adenosine monophosphate, adenosine, α-D-glucoside, β-D-glucoside, β-D-glucuronide, β-D-mannoside, β-D-mannoside, β-D-fructofuranoside, β-glucosiduronate, 5-acetamido-3,5-dideoxy-α-D-glycero-D-galacto-2-nonulopyranoside, alkoxy derivatives of 5-acetamido-3,5-dideoxy-α-D-glycero-D-galacto-2-nonulopyranoside, p-toluenesulfonyl-L-arginine ester, and p-toluenesulfonyl-L-arginine amide;

Z is a halo, alkoxy or alkyl group; and

T is H, an electron donating group, an electron withdrawing group, or an organic linker group which may be attached to an ancillary fluorophore or to a biological moiety.

2. The chemiluminescent substrate delivery system of claim 1 , wherein the linker moiety is represented by the formula:

wherein:

n is a positive integer;

A is H, alkyl, trihaloalkyl or aryl and

B is independently NA, NC(O)A, O, S or CH 2 .

3. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent substrate delivery system is represented by the formula:

4. The chemiluminescent substrate delivery system of claim 3 , wherein the linker moiety is represented by the formula:

wherein:

n is a positive integer;

A is H, alkyl, trihaloalkyl or aryl; and

B is independently NA, NC(O)A, O, S or CH 2 .

5. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent substrate delivery system is represented by the formula:

6. The chemiluminescent substrate delivery system of claim 5 , wherein the linker moiety is represented by the formula:

wherein

n is a positive integer;

A is H, alkyl, trihaloalkyl or aryl; and

B is independently NA, NC(O)A, O, S or CH 2 .

7. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent substrate delivery system is represented by the formula:

8. The chemiluminescent substrate delivery system of claim 7 , wherein the linker moiety is represented by the formula:

wherein:

n is a positive integer;

A is H, alkyl, trihaloalkyl or aryl; and

B is independently NA, NC(O)A, O, S or CH 2 .

9. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent enhancing moieties are formed by coupling a chemiluminescent enhancing molecule to a reactive site on the dendrimer or by chemically modifying a reactive site on the dendrimer to an enhancing moiety.

10. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent enhancing moieties are formed by peralkylation of amino groups on the dendrimer or by peralkylcarbonylation of amino groupds on the dendrimer by alkylation of amide groups on the dendrimer.

11. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent enhancing moieties are formed by reaction of carboxylate groups on the dendrimer with an amino linked ammonium, phosphonium or sulfonium salt.

12. The chemiluminescent substrate delivery system of claim 1 , wherein the chemiluminescent substrate and/or the dendrimer comprises one or more water solubilizing groups.

13. The chemiluminescent substrate delivery system of claim 12 , wherein the one or more water solubilizing groups are selected from the group consisting of carboxylic acids, esters, alkyl-oxides, aryl-oxides, alkyl-amides, aryl-amides, aralkyl-amides, alkyl-urethanes, aryl-urethanes, alkyl-sulfonamides, aryl-sulfonamides, alkyl-sulfonic acids, aryl-sulfonic acids, quaternary ammonium salts, and combinations thereof.

14. A chemiluminescent substrate delivery system comprising a first dendrimer represented by a formula selected from the group consisting of:

wherein:

“Linker” represents a linker moiety;

“Dendrimer” represents a dendrimer moiety resulting from the reaction of a surface functional group on the dendrimer with a functional group on the linker moiety;

N is a positive integer representing the number of chemiluminescent substrates conjugated to the dendrimer moiety;

Y is H, a hydroxyl group, a halogen, an substituted alkyl group, a hydroxy substituted alkyl group, a halogen substituted alkyl group, a phenyl group, a halogenated phenyl group, an alkoxy substituted phenyl group, an alkoxy phenoxy group, a hydroxy alkoxy group, a cyano group, an amide group, an alkoxy group or a carboxyl group;

R is a C 1 –C 12 alkyl, mono-, di-, or trihaloalkyl, an aryl or an aralkyl;

X is an enzyme-labile group selected from the group consisting of a phosphate, galactoside, acetate, 1-phospho-2,3-diacylglyceride, 1-thio-D-glucoside, adenosine triphosphate, adenosine diphosphate, adenosine monophosphate, adenosine, α-D-glucoside, β-D-glucoside, β-D-glucuronide, β-D-mannoside, β-D-mannoside, β-D-fructofuranoside, β-glucosiduronate, 5-acetamido-3,5-dideoxy-α-D-glycero-D-galacto-2-nonulopyranoside, alkoxy derivatives of 5-acetamido-3,5 -dideoxy-α-D-glycero-D-galacto-2-nonulopyranoside, p-toluenesulfonyl-L-arginine ester, and p-toluenesulfonyl-L-arginine amide;

Z is a halo, alkoxy or alkyl group; and

T is H, an electron donating group, an electron withdrawing group, or an organic linker group which may be attached to an ancillary fluorophore or to a biological moiety and

a second dendrimer comprising a chemiluminescent enhancing moiety;

wherein the second dendrimer is covalently or ionically associated with the first dendrimer.

15. The chemiluminescent substrate delivery system of claim 14 , wherein the linker moiety is represented by the formula:

wherein:

n is a positive integer;

A is H, alkyl, trihaloalkyl or aryl; and

B is independently NA, NC(O)A, O, S or CH 2 .

16. The chemiluminescent substrate delivery system of claim 14 , wherein the first dendrimer has a structure represented by the formula:

17. The chemiluminescent substrate delivery system of claim 14 , wherein the first dendrimer has a structure represented by the formula:

18. The chemiluminescent substrate delivery system of claim 14 , wherein the first dendrimer has a structure represented by the formula:

19. The chemiluminescent substrate delivery system of claim 14 , wherein the first dendrimer has a structure represented by the formula:

20. The chemiluminescent substrate delivery system of claim 14 , wherein the chemiluminescent enhancing moieties are formed by coupling a chemiluminescent enhancing molecule to a reactive site on the second dendrimer or by chemically modifying a reactive site on the second dendrimer to an enhancing moiety.

Assignments (9)

Continuity (3)